Influence of Clinical Parameters on the Efficacy of Immune Checkpoint Inhibitors in Patients with Non-Small Cell Lung Cancer Brain Metastases (NSCLCBM)

被引：0
|
作者：
Lauko, Adam
Thapa, Bicky
Muhsen, Baha'eddin
Borghei-Razavi, Hamid
Chao, Samuel
Suh, John
Pennell, Nathan
Ahluwalia, Manmeet
机构：
来源：
JOURNAL OF NEUROSURGERY | 2019年 / 131卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
418
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease
    Matsumoto, Kinnosuke
    Adachi, Yuichi
    Enomoto, Takatoshi
    RESPIROLOGY, 2020,
  • [22] Efficacy and predictors of rechallenge with immune checkpoint inhibitors in non-small cell lung cancer
    Takahara, Yutaka
    Tanaka, Takuya
    Ishige, Yoko
    Shionoya, Ikuyo
    Yamamura, Kouichi
    Sakuma, Takashi
    Nishiki, Kazuaki
    Nakase, Keisuke
    Nojiri, Masafumi
    Kato, Ryo
    Shinomiya, Shohei
    Fujimoto, Yuki
    Oikawa, Taku
    Mizuno, Shiro
    THORACIC CANCER, 2022, 13 (04) : 624 - 630
  • [23] Explore the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients of different gender
    Zheng, S-Y.
    Cui, H-J.
    ANNALS OF ONCOLOGY, 2020, 31 : S715 - S715
  • [24] Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with liver metastases
    Fan-jie Qu
    Yi Zhou
    Shuang Wu
    British Journal of Cancer, 2024, 130 : 165 - 175
  • [25] Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors
    Hendriks, Lizza E. L.
    Bootsma, Gerben
    Mourlanette, Jean
    Henon, Clemence
    Mezquita, Laura
    Ferrara, Roberto
    Audigier-Valette, Clarisse
    Mazieres, Julien
    Lefebvre, Corentin
    Duchemann, Boris
    Cousin, Sophie
    le Pechoux, Cecile
    Botticella, Angela
    De Ruysscher, Dirk
    Dingemans, Anne-Marie C.
    Besse, Benjamin
    EUROPEAN JOURNAL OF CANCER, 2019, 116 : 182 - 189
  • [26] The effects of immune checkpoint inhibitors vs. chemotherapy combined with brain radiotherapy in non-small cell lung cancer patients with brain metastases
    Tengfei Wang
    Rumeng Li
    Shuyan Liu
    Qiuji Wu
    Wen Ouyang
    Conghua Xie
    BMC Cancer, 24 (1)
  • [27] Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases
    Mahashabde, Ruchira, V
    Bhatti, Sajjad A.
    Martin, Bradley C.
    Painter, Jacob T.
    Rodriguez, Analiz
    Ying, Jun
    Li, Chenghui
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (07)
  • [28] Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
    Haizhu Chen
    Yu Feng
    Yu Zhou
    Yunxia Tao
    Le Tang
    Yuankai Shi
    Cancer Immunology, Immunotherapy, 2022, 71 : 3071 - 3085
  • [29] Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
    Chen, Haizhu
    Feng, Yu
    Zhou, Yu
    Tao, Yunxia
    Tang, Le
    Shi, Yuankai
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (12) : 3071 - 3085
  • [30] The Effect of Asymptomatic and/or Treated Brain Metastases on Efficacy of Immune Checkpoint Inhibitors in Metastatic Non-Small Cell Lung Cancer: A Meta-Analysis
    Li, Sihan
    Zhang, Hongwei
    Liu, Tingting
    Chen, Jun
    Dang, Jun
    FRONTIERS IN ONCOLOGY, 2021, 11
12345